NASDAQ:TLGT - Teligent Stock Price, Forecast & News

Teligent trades on the NASDAQ under the ticker symbol "TLGT."

Teligent Inc (NASDAQ:TLGT) issued its quarterly earnings data on Monday, November, 4th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.03) by $0.01. The company had revenue of $18.47 million for the quarter, compared to the consensus estimate of $19.82 million. Teligent had a negative net margin of 51.29% and a negative return on equity of 232.25%. View Teligent's Earnings History.

Teligent is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Teligent.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teligent in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Teligent.

News articles about TLGT stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Teligent earned a news sentiment score of 1.5 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Teligent.

Teligent saw a decrease in short interest in December. As of December 31st, there was short interest totalling 7,230,000 shares, a decrease of 10.1% from the December 15th total of 8,040,000 shares. Based on an average trading volume of 363,900 shares, the short-interest ratio is currently 19.9 days. Currently, 16.6% of the shares of the stock are sold short. View Teligent's Current Options Chain.

Some companies that are related to Teligent include Elite Pharmaceuticals (ELTP), ASLAN PHARMACEU/ADR (ASLN), ESSA Pharma (EPIX), IMMUTEP LTD/S (IMMP), Catabasis Pharmaceuticals (CATB), Trevena (TRVN), CTI BioPharma (CTIC), Neos Therapeutics (NEOS), Eyenovia (EYEN), Oncolytics Biotech (ONCY), Cumberland Pharmaceuticals (CPIX), Aclaris Therapeutics (ACRS), NewLink Genetics (NLNK), VERONA PHARMA P/S (VRNA) and Vaccinex (VCNX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Teligent investors own include Novavax (NVAX), ChemoCentryx (CCXI), Voyager Therapeutics (VYGR), Aquinox Pharmaceuticals (AQXP), General Electric (GE), Akorn (AKRX), Selecta Biosciences (SELB), Bausch Health Companies (BHC), Ford Motor (F) and Biocept (BIOC).

Teligent's stock is owned by a number of of retail and institutional investors. Top institutional investors include Sanders Morris Harris LLC (3.90%) and Wedbush Securities Inc. (0.21%). Company insiders that own Teligent stock include Bhaskar Chaudhuri, Carole Ben-Maimon, Damian Finio, James C Gale, Jason Grenfell-Gardner and Stephen Richardson. View Institutional Ownership Trends for Teligent.

TLGT stock was sold by a variety of institutional investors in the last quarter, including Sanders Morris Harris LLC. View Insider Buying and Selling for Teligent.

TLGT stock was acquired by a variety of institutional investors in the last quarter, including Wedbush Securities Inc.. Company insiders that have bought Teligent stock in the last two years include Bhaskar Chaudhuri, Carole Ben-Maimon, Damian Finio, James C Gale, Jason Grenfell-Gardner and Stephen Richardson. View Insider Buying and Selling for Teligent.

Shares of TLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TLGT stock can currently be purchased for approximately $0.40.

Teligent has a market capitalization of $21.69 million and generates $65.86 million in revenue each year. The company earns $-36,260,000.00 in net income (profit) each year or ($0.33) on an earnings per share basis. Teligent employs 189 workers across the globe.View Additional Information About Teligent.

The official website for Teligent is http://www.teligent.com/.

Teligent's mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company can be reached via phone at 856-697-1441 or via email at [email protected]